Quantifying homo- and heteromolecular hydrogen bonds as a guide for adduct formation.
暂无分享,去创建一个
William Jones | Peter T. A. Galek | Elna Pidcock | E. Pidcock | W. Jones | Amit Delori | Peter T A Galek | A. Delori
[1] Colin R. Groom,et al. One in half a million: a solid form informatics study of a pharmaceutical crystal structure , 2012 .
[2] P. Bag,et al. Co-Crystals of Sulfamethazine with Some Carboxylic Acids and Amides: Co-Former Assisted Tautomerism in an Active Pharmaceutical Ingredient and Hydrogen Bond Competition Study , 2011 .
[3] R. Suryanarayanan,et al. Unintended water mediated cocrystal formation in carbamazepine and aspirin tablets. , 2011, Molecular pharmaceutics.
[4] Christopher A. Hunter,et al. Virtual cocrystal screening , 2011 .
[5] Ranjit Thakuria,et al. Highly soluble olanzapinium maleate crystalline salts , 2011 .
[6] A. Rajbanshi,et al. Mapping out the synthetic landscape for re-crystallization, co-crystallization and salt formation , 2010 .
[7] L. Fábián,et al. New solid forms of artemisinin obtained through cocrystallisation , 2010 .
[8] William Jones,et al. Benefits of cocrystallisation in pharmaceutical materials science: an update , 2010, The Journal of pharmacy and pharmacology.
[9] D. Braga,et al. Remarkable reversal of melting point alternation by co-crystallization , 2010 .
[10] J. Steed,et al. Anion-switchable supramolecular gels for controlling pharmaceutical crystal growth , 2010, Nature Chemistry.
[11] Geoff G. Z. Zhang,et al. Pharmaceutical nano-cocrystals: sonochemical synthesis by solvent selection and use of a surfactant. , 2010, Angewandte Chemie.
[12] G. Desiraju,et al. Molecular complexes of alprazolam with carboxylic acids, boric acid, boronic acids, and phenols. Evaluation of supramolecular heterosynthons mediated by a triazole ring. , 2010, Journal of pharmaceutical sciences.
[13] Miranda L. Cheney,et al. Supramolecular Architectures of Meloxicam Carboxylic Acid Cocrystals, a Crystal Engineering Case Study , 2010 .
[14] Peter T. A. Galek,et al. The impact of accessible surface on hydrogen bond formation , 2010 .
[15] Frank H. Allen,et al. Truly prospective prediction: inter- and intramolecular hydrogen bonding , 2010 .
[16] Peter T. A. Galek,et al. Universal prediction of intramolecular hydrogen bonds in organic crystals. , 2010, Acta crystallographica. Section B, Structural science.
[17] D. Good,et al. Cocrystal Eutectic Constants and Prediction of Solubility Behavior , 2010 .
[18] Miranda L. Cheney,et al. Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of Lamotrigine , 2010 .
[19] Christer B. Aakeröy,et al. Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug. , 2009, Journal of the American Chemical Society.
[20] Peter T. A. Galek,et al. Knowledge-based H-bond prediction to aid experimental polymorph screening , 2009 .
[21] William Jones,et al. Improving Mechanical Properties of Crystalline Solids by Cocrystal Formation: New Compressible Forms of Paracetamol , 2009 .
[22] Naír Rodríguez-Hornedo,et al. Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility , 2009 .
[23] Jose Fayos. Molecular Crystal Prediction Approach by Molecular Similarity: Data Mining on Molecular Aggregation Predictors and Crystal Descriptors , 2009 .
[24] B. Sarma,et al. Synthon Competition and Cooperation in Molecular Salts of Hydroxybenzoic Acids and Aminopyridines , 2009 .
[25] Tejender S. Thakur,et al. Co-Crystals of the Anti-HIV Drugs Lamivudine and Zidovudine , 2009 .
[26] László Fábián,et al. Cambridge Structural Database Analysis of Molecular Complementarity in Cocrystals , 2009 .
[27] P. Karamertzanis,et al. Can the Formation of Pharmaceutical Cocrystals Be Computationally Predicted? I. Comparison of Lattice Energies , 2009 .
[28] Elies Molins,et al. Effect of the Counterion on the Solubility of Isostructural Pharmaceutical Lamotrigine Salts , 2009 .
[29] K. Arora,et al. Hierarchy of Supramolecular Synthons: Persistent Carboxylic Acid···Pyridine Hydrogen Bonds in Cocrystals That also Contain a Hydroxyl Moiety , 2008 .
[30] Tejender S. Thakur,et al. Crystal Structure Prediction of a Co-Crystal Using a Supramolecular Synthon Approach: 2-Methylbenzoic Acid−2-Amino-4-methylpyrimidine , 2008 .
[31] R. Davey,et al. On the solubility of saccharinate salts and cocrystals , 2008 .
[32] E. Suresh,et al. pK(a)-directed host-guest assemblies: rational analysis of molecular adducts of 2,4-diamino-6-methyl-1,3,5-triazine with various aliphatic dicarboxylic acids. , 2008, Chemistry.
[33] Peter T. A. Galek,et al. Knowledge-based model of hydrogen-bonding propensity in organic crystals. , 2007, Acta crystallographica. Section B, Structural science.
[34] Christer B Aakeröy,et al. Constructing, deconstructing, and reconstructing ternary supermolecules. , 2007, Chemical communications.
[35] T. Row,et al. Hydrogen bonding in pyrimethamine hydrogen adipate , 2007 .
[36] Orn Almarsson,et al. Performance comparison of a co-crystal of carbamazepine with marketed product. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[37] Christer B Aakeröy,et al. Cocrystal or salt: does it really matter? , 2007, Molecular pharmaceutics.
[38] Ron J Roberts,et al. Structure, solubility, screening, and synthesis of molecular salts. , 2007, Journal of pharmaceutical sciences.
[39] W. Jones,et al. Screening for crystalline salts via mechanochemistry. , 2006, Chemical communications.
[40] K. A. Padmanabhan,et al. Structure−Property Correlations in Bending and Brittle Organic Crystals , 2006 .
[41] G. Desiraju,et al. Synthon robustness in saccharinate salts of some substituted pyridines , 2006 .
[42] W. Motherwell,et al. Physical stability enhancement of theophylline via cocrystallization. , 2006, International journal of pharmaceutics.
[43] Aeri Park,et al. Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.
[44] Frank H. Allen,et al. Knowledge-based approaches to crystal design , 2006 .
[45] E. Suresh,et al. Nucleobases in molecular recognition: molecular adducts of adenine and cytosine with COOH functional groups. , 2005, Angewandte Chemie.
[46] J. McMahon,et al. Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients. , 2005, Chemical communications.
[47] Gautam R. Desiraju,et al. Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities , 2005 .
[48] A. Nangia,et al. Tape and layer structures in cocrystals of some di- and tricarboxylic acids with 4,4′-bipyridines and isonicotinamide. From binary to ternary cocrystals , 2005 .
[49] G. Desiraju,et al. Saccharin as a salt former. Enhanced solubilities of saccharinates of active pharmaceutical ingredients. , 2005, Chemical communications.
[50] William Jones,et al. Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .
[51] W. Motherwell,et al. Hydrogen bond competition between chemical groups: new methodology and the Cambridge Structural Database , 2005 .
[52] Christopher A. Hunter. Zwischenmolekulare Wechselwirkungen in Lösung: eine vereinfachende Quantifizierungsmethode , 2004 .
[53] C. Hunter,et al. Quantifying intermolecular interactions: guidelines for the molecular recognition toolbox. , 2004, Angewandte Chemie.
[54] Orn Almarsson,et al. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2003, Chemical communications.
[55] M. Winter,et al. Isomorphism and Crystal Engineering: Organic Ionic Ladders Formed by Supramolecular Motifs in Pyrimethamine Salts , 2003 .
[56] Orn Almarsson,et al. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.
[57] J. McMahon,et al. Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.
[58] W. Jones,et al. Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics. , 2002, Chemical communications.
[59] P. Luger,et al. Crystal Engineering of Organic Salts: Hydrogen-Bonded Supramolecular Motifs in Pyrimethamine Hydrogen Glutarate and Pyrimethamine Formate , 2002 .
[60] P. Muthiah,et al. Hydrogen‐bonded supramolecular ribbons in the antifolate drug pyrimethamine , 2002 .
[61] Gautam R. Desiraju,et al. Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis , 1995 .
[62] Gautam R. Desiraju. Supramolekulare Synthone für das Kristall‐Engineering ‐ eine neue organische Synthese , 1995 .